Natco Pharma Q3 Results

  • BSE: 524816
  • NSE: NATCOPHARM
  • ISIN: INE987B01026
  • Sector: Biotechnology & Drugs
BSE
1,369.213.20 (0.97%)
Volume17.41 K
Updated: Mon 25 Nov, 2024 | 15:29:00
NSE
1,364.957.35 (0.54%)
Volume5.72 L
Updated: Mon 25 Nov, 2024 | 15:43:45
Today: 1,355.45
1,383.50
52-Wk: 752.55
1,638.35

Q3 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Natco Pharma Q3 Results

    *All figures in crores except per share values
    Fiscal PeriodDec 23Sep 23QoQ CompDec 22YoY Comp
    Total Revenue 758.601,031.40-%492.50-%
    Selling/ General/ Admin Expenses Total 121.90122.40-%105.60-%
    Depreciation/ Amortization 44.2043.60-%41.50-%
    Other Operating Expenses Total 206.40235.20-%165.60-%
    Total Operating Expense 534.70617.00-%428.10-%
    Operating Income 223.90414.40-%64.40-%
    Net Income Before Taxes 256.30439.60-%81.40-%
    Net Income 212.70369.00-%62.30-%
    Diluted Normalized EPS 11.8820.60-%3.41-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts